AsthmaPhase 2TRECONYNCT07301736
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
A Phase 2 study testing CHF5993 pMDI with HFA-152a, CHF5993 pMDI with HFA-134a and CHF718 pMDI with HFA-134a in people with Asthma, run by Chiesi Farmaceutici S.p.A. at 167 sites in 14 countries.
Trial summary
This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. We want to make sure both versions of the inhaler work the same way for people with mild to moderate asthma. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Asthma
- What is being tested?
- CHF5993 pMDI with HFA-152a, CHF5993 pMDI with HFA-134a and CHF718 pMDI with HFA-134a
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 780 participants
- Where
- 167 sitesin 14 countries
- Study dates
- 17 Dec 2025to 3 Jun 2027
- Phase
- Phase 2
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male and female adults (18 ≤ age ≤ 75 years) with a diagnosis of Asthma for at least 6 months prior to screening and with diagnosis before the age of 50 years;
- Non-smokers, ex-smokers;
- Body mass index: within the range of 18.0 to 35.0 kg/m2 inclusive;
- Stable asthma therapy: a stable maintenance treatment for at least 4 weeks prior to screening with:
- low or medium doses of ICS (Inhaled Corticosteroids) alone; or
- low or medium doses of ICS + LABA (Long-acting β2-agonist) (fixed or free combination).
Show all 9Show fewer
- Controlled or partly controlled based on an Asthma Control Questionnaire - 7 Items (ACQ-7) score <1.5 at screening and at randomisation.
- Pre-BD (Bronchodilator) FEV1 >40% and <90% of the predicted normal value, after appropriate wash out from BDs, at the Screening Visit (V1).
- A demonstrated increase in either FEV1 or forced vital capacity of >12% and >200 mL from baseline within 30 minutes (min) after inhalation of 400 µg salbutamol (i.e. albuterol) pMDI at the Screening Visit (V1).
Who cannot join
- History of near fatal asthma or hospitalisation for asthma in intensive care unit, inpatient setting or emergency room access for asthma in the previous 6 months prior to screening, which in the judgement of the Investigator may place the subjects at undue risk;
- Recent asthma exacerbation requiring systemic corticosteroids (SCSs), or emergency room admission or hospitalisation within 3 months prior to screening and/or during the run-in period ;
- Non-persistent asthma: exercise-induced, seasonal asthma (as the only asthma-related diagnosis) not requiring daily asthma control medicine;
- Asthma subjects currently treated with any of the following :
- High dose ICS;
- Long-acting muscarinic antagonist (LAMA);
Show all 16Show fewer
- Systemic, depot or slow-release corticosteroids within 12 weeks prior to screening;
- Any other asthma treatments (e.g. cromolyn sodium, nedocromil sodium, leukotriene modifiers) within 4 weeks prior to screening;
- Any biologic therapy (e.g. omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab, tezepelumab) within 6 months prior to screening;
- Respiratory disorders other than asthma
- Lung resection;
- Lower respiratory tract infection;
- Lung cancer and history of lung cancer;
- Subjects with active cancer or a history of cancer (other than lungs) ;
- Patients who have clinically significant cardiovascular condition;
- Run-in compliance: e-Diary completion <75% and run-in treatment compliance <75% at randomisation;
Trial locations and contacts
167 sites in 14 countries. Contact the study team or a site near you to ask about taking part.
Chiesi Clinical Trial Info Chiesi Clinical Trials contact
167 sites in 14 countries
Argentina27 sites, 27 recruiting
- Recruiting
Hospital Británico de Buenos Aires_Site n. 032029
Buenos Aires, 1275
Alejandro Salvado
- Recruiting
Centro Medico de Enfermedades Respiratorias_Site n. 032002
Buenos Aires, 1602
Miguel Angel Bergna
- Recruiting
Centro Medico Respire_Site n. 032014
Buenos Aires, 1646
Reynaldo Marciano Smith
- Recruiting
Asociación de Fomento y Sala de Primeros Auxilios "Alberto Mignaburu"_Site n. 032018
Buenos Aires, 1887
Rocio Fernandez Bazerque
- Recruiting
Centro de Investigaciones Médicas Mar del Plata_Site n. 032019
Buenos Aires, 7600
Manuel Naveyra
- Recruiting
Fundacion CIDEA_Site n. 032009
Buenos Aires, C1121ABE
Jorge Maspero
- Recruiting
Centro Medico Arsema_Site n. 032003
Buenos Aires, C1427BCR
Marcelo Casas
- Recruiting
Centro de Investigaciones Metabólicas (CINME)_Site n. 032025
Ciudad Autonoma de Buenos Aire, 1056ABJ
Gonzalo Saenz
- Recruiting
Centro de Medicina Respiratoria - Concepcion del Uruguay_Site n. 032015
Ciudad Autonoma de Buenos Aire, 1056ABJ
Carlos Victorio
- Recruiting
CARE - Centro de Alergia y Enfermedades Respiratorias_Site n. 032028
Ciudad Autonoma de Buenos Aire, 1414
Andrea Di Cianni
- Recruiting
Consultorio Medico Dra. Rivera_Site n. 032012
Ciudad Autonoma de Buenos Aire, 1426
Mariana Rivera
- Recruiting
Fundación Respirar Salud_Site n. 032004
Ciudad Autonoma de Buenos Aire, 1426
Maria Cristina De Salvo
- Recruiting
Instituto de Medicina Respiratoria (IMER) - Cordoba_Site n. 032023
Córdoba, X5003DCE
Alexis Cazaux
- Recruiting
CePIR_Site n. 032021
La Plata, 1900
Gabriel Garcia
- Recruiting
Fundacion Scherbovsky_Site n. 032013
Mendoza, 5500
Pablo Saez Scherbovsky
- Recruiting
Instituto Medico INSARES SA_Site n. 032005
Mendoza, 5500
Pedro Elias
- Recruiting
Cimro Consultorios Medicos - Centro de Investigacion_Site n. 032006
Mendoza, 5600
Ernesto Raso
- Recruiting
Centro Respiratorio Quilmes_Site n. 032007
Quilmes, 1878
Marcelo Jose Fernandez
- Recruiting
Fundacion Innovaciencia_Site n. 032017
Rosario, 2000
German Arce
- Recruiting
Instituto de Especialidades de la Salud Rosario_Site n. 032020
Rosario, 2000
Dario Ardusso
- Recruiting
Instituto Medico de la Fundacion de Estudios Clínicos_Site n. 032001
Rosario, 2000
Tomas Alvarez
- Recruiting
Fundacion Grupo Colaborativo Rosario_Site n. 032010
Rosario, 2132
Fernando Massola Adrian
- Recruiting
Instituto De Enfermedades Respiratorias E Investigacion Medica (IERIM)_Site n. 032011
San Juan Bautista, 1888
Andrea Medina
- Recruiting
Centro Modelo de Cardiologia SRL_Site n. 032016
San Miguel de Tucumán, 4000
Roxana Maricel Willigs Rolon
- Recruiting
Clinica Mayo de UMCB SRL_Site n. 032026
San Miguel de Tucumán, 4000
María Mercedes Espeche
- Recruiting
Investigaciones en Patologias Respiratorias_Site n. 032022
San Miguel de Tucumán, T4000
Ana Maria Stok
- Recruiting
IBAMEDICA_Site n. 032008
Santa Fe, 3000
Martin Edgardo Maillo
Bulgaria21 sites, 21 recruiting
- Recruiting
MHAT Sv. Ivan Rilski - Gorna Oryahovitsa_Site n.100017
Gorna Oryahovitsa, 5100
Ivancho Draganchev
- Recruiting
Medical Center Pulmo - 2018_Site n. 100007
Haskovo, 6300
Veselin Kalfov
- Recruiting
MC ZDRAVE 1 - Kozloduy_Site n. 100009
Kozloduy, 3320
Rumen Stoyanov Tiholov
- Recruiting
Medical Centre Pratia Clinic EOOD - Lovech_Site n. 100012
Lovech, 5500
Mihail Kirov
- Recruiting
Specialized Hospital for Active Treatment of Pulmonary Diseases - Pernik EOOD_Site n. 100020
Pernik, 2300
Galina Petrova
- Recruiting
Multiprofile Hospital for Active Treatment "Heart and Brain" EAD_Site n. 100019
Pleven, 5804
Iliya Krachunov
- Recruiting
Medical Centre ''Unimed'' EOOD_Site n. 100003
Plovdiv, 4000
Maria Dimitrova
- Recruiting
MHAT "St. Ivan Rilski "- Razgrad_Site 100013
Razgrad, 7200
Oleg Nemechkin
- Recruiting
Outpatient Practice for Specialized Medical Care in Allergology- Dr. Talyat Sali Cholak EOOD_Site 100002
Razgrad, 7200
Talyat Cholak
- Recruiting
Re Spiro Medical Center_Site n. 100018
Razgrad, 7200
Ivan Kiselov
- Recruiting
Medical Center Hermes Ruse_Site n. 100011
Rousse, 7002
Nikolay Nikolaev
- Recruiting
SHATPPD "Dr. Dimitar Gramatikov" Ruse EOOD_Site n. 100004
Rousse, 7002
Elena Docheva
- Recruiting
Multiprofile Hospital for Active Treatment "Dr. Ivan Seliminski" - Sliven AD_Site n.100014
Sliven, 8800
Petyo Petkov
- Recruiting
Medical Center Hera EOOD_Site n. 100006
Sofia, 1000
Gergana Ilieva-Georgieva
- Recruiting
University First Multiprofile Hospital for Active Treatment - Sofia "St. John the Baptist"_Site n. 100016
Sofia, 1142
Dinko Valev
- Recruiting
Specialized Hospital for Active Treatment Pneumo- Phthisiatric Diseases - Sofia District EOOD_Site n. 100021
Sofia, 1202
Nadya Koteva
- Recruiting
Multi-profile hospital for active treatment Lozenets EAD_Site n. 100008
Sofia, 1407
Svetlomir Takov
- Recruiting
Preventsia 2000 - Medical Centre for Outpatient Medical Care OOD_Site n. 100005
Stara Zagora, 6000
Vanya Dimova Ilieva-Fartunova
- Recruiting
University Multiprofile Hospital for Active Treatment "Prof. Dr. Stoyan Kirkovich" AD_Site n.100015
Stara Zagora, 6000
Damyan Arabadzhiev
- Recruiting
Medical Centre New Rehabilitation Centre EOOD_Site n. 100010
Stara Zagora, 6001
Gyongyver Szaloky
- Recruiting
Medical Centre Pratia Clinic EOOD - Varna_Site 100001
Varna, 9020
Iskra Velichkova
Germany19 sites, 19 recruiting
- Recruiting
Velocity Clinical Research Germany, Ahrensburg_Site n. 276020
Ahrensburg, 22926
Sameer Kulkarni
- Recruiting
Studienpraxis Berlin-Brandenburg_Site n. 276005
Berlin, 10119
Lennart Schaper
- Recruiting
Praxis an der Oper_Site n. 276016
Berlin, 10625
Thomas Lienert
- Recruiting
Lungenpraxis Hohenzollerndamm_Site n. 276004
Berlin, 10717
Anneliese Linnhoff
- Recruiting
Velocity Clinical Research Germany GmbH_Site 276010
Berlin, 10787
Isabelle Schenkenberger
- Recruiting
Polikum Institut GmbH_Site n. 276006
Berlin, 12157
Michael Sebert
- Recruiting
Institute for Allergy and Asthma Research Berlin, IAAB_Site n. 276008
Berlin, 12159
Matthias Kruell
- Recruiting
MECS research GmbH_Site 276011
Berlin, 12203
Thomas Schultz
- Recruiting
MECS Cottbus GmbH_Site n. 276007
Cottbus, 03050
Iwona Cwiek
- Recruiting
Klifeck GmbH_Site n. 276002
Delitzsch, 04509
Gerald Eckhardt
- Recruiting
Schwerpunktpraxis Lungen- und Bronchialheilkunde Allergologie und Schlafmedizin_Site n. 276009
Düsseldorf, 40217
Ulrike Neise
- Recruiting
Velocity Clinical Research Germany GmbH_Site n. 276019
Hamburg, 20095
Anastasia Kelidou
- Recruiting
Gemeinschaftspraxis für Pneumologie, Allergologie und Schlafmedizin_Site n. 276012
Ibbenbueren, 49477
Christoph Stolpe
- Recruiting
Pulmologische Praxis Dr. Brunner_Site n. 276013
Leipzig, 04157
Falk Brunner
- Recruiting
Velocity Clinical Research Leipzig GmbH_Site n. 276018
Leipzig, 04177
Thomas Muller
- Recruiting
Practice for pneumology and allergology_Site n. 276021
Leipzig, 04299
Gerhard Hoheisel
- Recruiting
POIS Sachsen_Site n. 276001
Leipzig, 04347
Juliana Brode
- Recruiting
Zentrum Fur Ambulante Pneumologische Forschung Mbg GbR_Site n. 276015
Marburg, 35037
Lukas Jerrentrup
- Recruiting
Ballenberger, Freytag, Wenisch - Institut fuer Klinische Forschung GmbH_Site n. 276014
Neu-Isenburg, 63263
Sabine Ballenberger
Ukraine15 sites, 15 recruiting
- Recruiting
Chernivtsi Regional Clinical Hospital_Site n. 804006
Chernivtsi, 58000
Svitlana Kovalenko
- Recruiting
Clinical Hospital of Emergency Medical Care of the Dnipro City Council Allergy Center_Site n. 804014
Dnipro, 49006
Evgeniya Dytyatkovska
- Recruiting
Ivano-Frankivsk City Clinical Hospital No. 1_Site n. 804003
Ivano-Frankivsk, 76012
Sergiy Fedorov
- Recruiting
The Ivano-Frankivsk National Medical Univeristy_Site n. 804004
Ivano-Frankivsk, 76018
Vira Myhovych
- Recruiting
Regional Centre of Phthisiology and Pulmonology - Ivano-Frankivsk Regional Council_Site n. 804009
Ivano-Frankivsk, 76019
Mykola Ostrovskyy
- Recruiting
Medical Center "ARTES MEDICUM" LLC_Site n. 804002
Kyiv, 02002
Dmytro Dobrianskyi
- Recruiting
National Scientific Center of Phthisiatry Pulmonology and Allergology after F.G. Yanovsky_Site n.804010
Kyiv, 03038
Nataliia Prymushko
- Recruiting
Institute of Gerontology im D. F. Chebotarova NAMS of Ukraine_Site n. 804001
Kyiv, 04114
Ervin Asanov
- Recruiting
Kyiv Railway Clinical Hospital No. 2 of Branch "Healthcare Center" of the PJSC "Ukrainian Railway"_Site n.804013
Kyiv, 3049
Bogdan Gundertaylo
- Recruiting
National Scientific Center of Phthisiatry Pulmonology and Allergology after F.G. Yanovsky_Site n. 804016
Kyiv, 3680
Volodymyr Gavrysyuk
- Recruiting
Odesa Regional Clinical Hospital of Odesa Regional Council_Site n. 804008
Odesa, 65025
Yuliia Novosolova
- Recruiting
Limited Liability Company Medical and Diagnostic Center "Medion"_Site n. 804007
Poltava, 36039
Ivan Kryvoruchko
- Recruiting
University Clinic of Vinnytsia National Medical University named after M.I. Pirogova_Site n. 804011
Vinnytsia, 21029
Sergii Shevchuk
- Recruiting
Vinnytsia City Clinical Hospital No. 1_Site n. 804005
Vinnytsia, 21029
Tetyana Konstantynovych
- Recruiting
Vinnytsia City Clinical Hospital No. 1_Site n. 804012
Vinnytsia, 21029
Nataliya Slepchenko
Romania13 sites, 13 recruiting
- Recruiting
Spitalul de Pneumoftiziologie Bacau_Site n. 642014
Bacau, 600252
Dragos Gabriel Ungureanu
- Recruiting
ANGISAN GRUP SRL_Site n. 642005
Bragadiru, 077025
Angelica Savu
- Recruiting
Pneumo Bronho Med_Site n. 642002
Brasov, 500051
Ionela Iovan
- Recruiting
Theramed Healthcare S.R.L._Site n. 642001
Brasov, 500051
Ioana Agache
- Recruiting
Spitalul Clinic Colentina_Site n. 642010
Bucharest, 020125
Poliana Leru
- Recruiting
Spitalul Clinic Nr.1 Cai Ferate Witing_Site n. 642008
Bucharest, 10243
Ana Maria Trailescu
- Recruiting
Delta Health Care S.R.L._Site n. 642006
Bucharest, 14461
Veronica Surlea
- Recruiting
Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie "Dr. Victor Babeș" Craiova_Site n. 642003
Craiova, 200515
Dragos Nicolosu
- Recruiting
SC Medical Center SRL_Site n. 642013
Deva, 330084
Ioan Petrui
- Recruiting
Spital De Pneumologie Dr. Lavinia Davidescu S.R.L._Site n. 642009
Oradea, 410290
Cristian Stefan Mago
- Recruiting
SC M-Profilaxis SRL_Site n. 642004
Timișoara, 300041
Carmen Panaitescu
- Recruiting
Neoclinic Concept S.R.L._Site n. 642011
Timișoara, 300298
Stefan Mihaicuta
- Recruiting
Spitalul Clinic de Boli Infecţioase si Pneumofiziologie "Dr. Victor Babes"_Site n. 642007
Timișoara, 300310
Cristian Oancea
South Africa13 sites, 13 recruiting
- Recruiting
Tiervlei Trial Centre_Site n. 710007
Bellville, 7530
Karla Morrison
- Recruiting
Worthwhile Clinical Trials_Site n. 710003
Benoni, 1501
Nazreen Jeewa Hussen
- Recruiting
IATROS International_Site n. 710008
Bloemfontein, 9301
Nyda Fourie
- Recruiting
Task Applied Science (TASK) - Central Location_Site n. 710015
Cape Town, 7530
Karla Morrison
- Recruiting
Precise Clinical Solutions_Site n. 710004
Chatsworth, 4092
Visvakuren Naidoo
- Recruiting
Synapta Clinical Research Centre_Site n. 710006
Durban, 4001
Farzana Hoosen
- Recruiting
TASK Eden_Site n. 710001
George, 6529
Suzanne Staples
- Recruiting
Meditrial_Site n. 710002
KwaZulu, 3201
Jessica Fryer
- Recruiting
Mzansi Ethical Research Centre (MERC)_Site n. 710005
Middelburg, 1050
Mohammed Siddique Tayob
- Recruiting
Johese Clinical Research - Centurion_Site 710010
Pretoria, 157
Johannes Giessing
- Recruiting
Botho Ke Bontle Healthcare Pty LTD_Site n. 710012
Pretoria, 184
Salphy Mokgadi Mogashoa
- Recruiting
Global Clinical Trials Pty Ltd_Site n. 710011
Pretoria, 83
Larisha Pillay-Ramaya
- Recruiting
Welkom Clinical Trial Centre_Site n. 710013
Welkom, 9460
Yacoob Vahed
Hungary11 sites, 11 recruiting
- Recruiting
Trial Pharma Kft. - TPKFT_Site n. 348011
Békéscsaba, 5600
Ibolya Vendrey-Laczo
- Recruiting
Edelenyi Koch Robert Korhaz Es Rendelointezet_Site n. 348013
Edelény, 3780
Melinda Szabo
- Recruiting
Szalay Janos Rendelointezet_Site n. 348006
Hajdúnánás, 4080
Aniko Kurucz
- Recruiting
BKS Research Kft._Site n. 348001
Hatvan, H-3000
Agota Bencze
- Recruiting
Bajcsy-Zsilinszky Korhaz es Rendelointezet_Site n. 348002
Monor, 2200
Zoltan Bende Bende
- Recruiting
Revamed Kft._Site n. 348004
Nyíregyháza, 4400
Valeria Csajbok
- Recruiting
Simplex Kft._Site n. 348007
Nyíregyháza, 4481
Tamas Kardos
- Recruiting
Trial Pharma Kft. - Szeged_Site n. 348010
Szeged, 6726
Gyongyver Szaloky
- Recruiting
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Rendelőintézet_Site n. 348003
Szolnok, 5000
Margit Biro
- Recruiting
Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz_Site n. 348005
Szombathely, 9700
Zsuzsanna Cseke
- Recruiting
K&B Sleepmed Kft_Site n. 348008
Szombathely, H-9700
Krisztina Hajdu
Serbia11 sites, 11 recruiting
- Recruiting
KBC "Dr Dragiša Mišović-Dedinje"_Site n. 688004
Belgrade, 11000
Vesna Djuric
- Recruiting
Klinicki Centar Srbije (KCS) - Klinika za Pulmologiju_Site n. 688009
Belgrade, 11000
Ana Samardzic
- Recruiting
Municipal Institute for Lung Disease and Tuberculosis_Site n. 688010
Belgrade, 11120
Gorana Sovljanski
- Recruiting
Klinički Centar Kragujevac_Site n. 688007
Kragujevac, 34000
Slavica Mojsilovic
- Recruiting
Klinički Centar Kragujevac_Site n. 688003
Kragujevac, 34111
Ivan Cekerevac
- Recruiting
Clinical Centre of Nis_Site n. 688011
Niš, 18000
Ivana Stankovic
- Recruiting
Institute for Lung Diseases and Tuberculosis - Nis_Site n. 688001
Niš, 18101
Sasa Jovanovic
- Recruiting
Institute for Pulmonary Diseases of Vojvodina_Site n. 688006
Novi Sad, 21000
Miroslav Ilic
- Recruiting
Institute for Pulmonary Diseases of Vojvodina_Site n. 688012
Sremska Mitrovica, 21208
Violeta Kolarov
- Recruiting
Zdravstveni Centar Užice_Site n. 688008
Užice, 31000
Zorica Radojevic
- Recruiting
Health Center Valjevo, General Hospital Valjevo_Site n. 688002
Valjevo, 14000
Dejan Sofronic
United Kingdom10 sites, 10 recruiting
- Recruiting
Ormeau Clinical Trials Ltd._Site n. 826005
Belfast, BT2 8BG
Damien McNally
- Recruiting
North Bristol NHS Trust - Southmead Hospital Bristol_Site n. 826010
Bristol, BS10 5NB
James Dodd
- Recruiting
Concord Medical Centre_Site n. 826009
Bristol, BS34 6BQ
James Case
- Recruiting
Elpida Trials - Parloes Hub_Site n. 826003
Dagenham, RM9 5QP
Ravali Goriparthi
- Recruiting
4 Medical Clinical Solutions (4MCS) - London_Site n. 826004
London, IG1 4HP
Martin Palin
- Recruiting
Maidstone and Tunbridge Wells NHS Trust - Maidstone Hospital_Site n. 826008
Maidstone, ME16 9QQ
Tuck-Kay Loke
- Recruiting
Medicines Evaluation Unit_Site n. 826006
Manchester, M23 9QZ
Dave Singh
- Recruiting
Accellacare South London_Site n. 826001
Orpington, BR5 3QG
Njobuenwnu Hyacienth Amah
- Recruiting
Portsmouth Hospitals NHS Trust - Queen Alexandra Hospital_Site n. 826002
Portsmouth, PO6 3LY
Thomas Brown
- Recruiting
Abbeywell Surgery_Site n. 826007
Romsey, SO51 8EN
Nicola Lester
Bosnia and Herzegovina9 sites, 9 recruiting
- Recruiting
University Clinical Centre of the Republic of Srpska - Paprikovac_Site n. 070004
Banja Luka, 78000
Maja Latincic
- Recruiting
Sveti apostol Luka Doboj_Site n. 070005
Doboj, 74000
Zeljana Panic
- Recruiting
Dr. Abdulah Nakas General Hospital_Site n. 070007
Sarajevo, 71000
Tijana Muhic-Skalonja
- Recruiting
Dr. Abdulah Nakas General Hospital_Site n. 070009
Sarajevo, 71000
Armin Hadzic
- Recruiting
Organizational unit Novi Grad_Site n. 070003
Sarajevo, 71000
Alisa Krivic
- Recruiting
University Clinical Hospital Mostar_Site n. 07001
Siroki Brijeg, 88226
Kristina Galic
- Recruiting
Opca Bolnica Tesanj_Site n. 070006
Tešanj, 74260
Besim Prnjavorac
- Recruiting
Dr. Mustafa Sehovic Public Medical Center_Site n. 070008
Tuzla, 75000
Edin Jusufovic
- Recruiting
University Clinical Centre Tuzla_Site n. 070002
Tuzla, 75000
Dzenan Halilovic
Czechia7 sites, 7 recruiting
- Recruiting
MEDITRIAL, s.r.o._Site n. 203003
Jindřichův Hradec, 377 01
Petr Kopecky
- Recruiting
Plicni Ambulance Louny s.r.o - Louny_Site n. 203001
Louny, 44001
Michala Cervena Sulcova
- Recruiting
Cefispiro s.r.o_Site n. 203006
Lovosice, 41002
Petra Filipova
- Recruiting
Nemocnice Mesice - Centrum integrovane onkologicke pece, z.s., Plicni ambulance_Site n. 203004
Měšice, 25064
Jaromir Musil
- Recruiting
MUDr. Ilona Pavlišová sro_Site n. 203007
Miroslav, 67271
Ilona Pavlisova
- Recruiting
Plicní středisko Teplice s.r.o._Site n. 203002
Teplice, 41501
Stanislav Holub
- Recruiting
PNEUMOLOGIE Varnsdorf_Site n. 203005
Varnsdorf, 40747
Milan Sklenar
Latvia5 sites, 5 recruiting
- Recruiting
VCA Polyclinic DUBULTI_Site n. 428006
Jūrmala, 2015
Natalija Visocka
- Recruiting
Riga 1st Hospital_Site n. 428003
Riga, 1001
Ilze Reinholde
- Recruiting
Paula Stradiņa Klīniskā Universitātes Slimnīca_Site n. 428001
Riga, 1002
Aurika Babjoniseva
- Recruiting
Consilium Medicum_Site n. 428002
Riga, 1010
Maris Bukovskis
- Recruiting
SIA Rigas Austrumu Kliniska Universitates Slimnica - Gailezers_Site n. 428005
Riga, 1038
Inga Vikmane
Mexico3 sites, 3 recruiting
- Recruiting
CIAID - Centro de Investigacion y Atencion Integral Durango, S.C._Site n. 484006
Durango, 34000
Ricardo Alberto Ramirez Terrones
- Recruiting
Centro Mexicano de Desarrollo de Estudios Clinicos (CEMDEC SA)_Site n. 484010
Mérida, 97130
Matilde Damian-Hernandez
- Recruiting
Centro Respiratorio de México_Site n. 484008
Mexico City, 14050
Raul Humberto Sansores Martínez
Slovakia3 sites, 3 recruiting
- Recruiting
Alian, s.r.o._Site n. 703001
Bardejov, 085 01
Maria Dzupinova
- Recruiting
DANIMED, spol. s r.o._Site n. 703003
Levice, 934 01
Daniela Hasicova
- Recruiting
Pľúcna Ambulancia Hrebenár, s.r.o._Site n. 703002
Spišská Nová Ves, 052 01
Slavomir Hrebenar
About this study
Official title: A Phase II Multinational, Multicentre, Double-blind, Randomised, Active-controlled, 3-way Cross-over Study to Evaluate the Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a Versus CHF5993 pMDI 100/6/12.5 µg HFA-134a in Subjects With Mild to Moderate Asthma
This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. We want to make sure both versions of the inhaler work the same way for people with mild to moderate asthma.
Read the detailed description
This global study aims to compare whether the investigational inhaler with the new HFA-152a propellant is as safe, effective and well tolerated in patients with asthma as the inhalers that use the existing HFA-134a propellant. HFA-152a is a propellant gas that is designed to have a lower global warming potential and to be more climate friendly. The study will be conducted in Europe, Latin America, Ukraine, South Africa and United Kingdom. It is planned to randomize 468 patients.
- Conditions
- Asthma
- Being tested
- CHF5993 pMDI with HFA-152a, CHF5993 pMDI with HFA-134a, CHF718 pMDI with HFA-134a
- Medical subject headings
- Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CHF5993 pMDI with HFA-152aDrug
two puffs BID (twice daily)
CHF5993 pMDI with HFA-134aDrug
two puffs BID
CHF718 pMDI with HFA-134aDrug
two puffs BID
| Study group | Role | What they receive |
|---|---|---|
| Test Treatment: CHF5993 pMDI (Pressurised Metered Dose Inhaler) with HFA-152a | Experimental | BDP (Beclometasone Dipropionate)/FF (Formoterol Fumarate)/GB (Glycopyrronium Bromide) 100/6/12.5 µg Receives: Drug: CHF5993 pMDI with HFA-152a |
| Reference Treatment 1: CHF5993 pMDI with HFA-134a | Active comparator | BDP/FF/GB 100/6/12.5 µg Receives: Drug: CHF5993 pMDI with HFA-134a |
| Reference Treatment 2: CHF718 pMDI with HFA-134a | Active comparator | BDP 100 µg Receives: Drug: CHF718 pMDI with HFA-134a |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in forced expiratory volume in 1 second (FEV1) area under the curve from time zero to 4 hours (AUC0-4h) on Day 1
Measured: Day 1
Change from baseline in pre-dose FEV1 on Day 28
Measured: Day 28
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Dec 2025
- Study start17 Dec 2025
- Primary completion3 Jun 2027 (estimated)
- Study completion3 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- More trials run by Chiesi Farmaceutici S.p.A.The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 780 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Piotr KUNA, MD, Principal investigator, Barlicki University Hospital Medical University of Lodz, Poland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07301736
- Sponsor's protocol ID
- CLI-05993AA9-01
- Other IDs
- 2025-521456-35-00, 2025
- Acronym
- TRECONY
- Status last verified
- Jun 2026
- First submitted
- 11 Dec 2025
- Last updated
- 25 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Phase II Multinational, Multicentre, Double-blind, Randomised, Active-controlled, 3-way Cross-over Study to Evaluate the Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a Versus CHF5993 pMDI 100/6/12.5 µg HFA-134a in Subjects With Mild to Moderate Asthma
- ClinicalTrials.gov ID
- NCT07301736
- Acronym / sponsor ID
- TRECONY / CLI-05993AA9-01
- Conditions
- Asthma
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 780 participants (estimated)
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry (pharma, biotech, devices)
- Study start
- 17 Dec 2025 (actual)
- Primary completion
- 3 Jun 2027 (estimated)
- Study completion
- 3 Jun 2027 (estimated)
- First posted
- 24 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. We want to make sure both versions of the inhaler work the same way for people with mild to moderate asthma.
Detailed description
This global study aims to compare whether the investigational inhaler with the new HFA-152a propellant is as safe, effective and well tolerated in patients with asthma as the inhalers that use the existing HFA-134a propellant. HFA-152a is a propellant gas that is designed to have a lower global warming potential and to be more climate friendly. The study will be conducted in Europe, Latin America, Ukraine, South Africa and United Kingdom. It is planned to randomize 468 patients.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Test Treatment: CHF5993 pMDI (Pressurised Metered Dose Inhaler) with HFA-152a | Experimental | Drug: CHF5993 pMDI with HFA-152aBDP (Beclometasone Dipropionate)/FF (Formoterol Fumarate)/GB (Glycopyrronium Bromide) 100/6/12.5 µg |
| Reference Treatment 1: CHF5993 pMDI with HFA-134a | Active comparator | Drug: CHF5993 pMDI with HFA-134aBDP/FF/GB 100/6/12.5 µg |
| Reference Treatment 2: CHF718 pMDI with HFA-134a | Active comparator | Drug: CHF718 pMDI with HFA-134aBDP 100 µg |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Male and female adults (18 ≤ age ≤ 75 years) with a diagnosis of Asthma for at least 6 months prior to screening and with diagnosis before the age of 50 years;
- Non-smokers, ex-smokers;
- Body mass index: within the range of 18.0 to 35.0 kg/m2 inclusive;
- Stable asthma therapy: a stable maintenance treatment for at least 4 weeks prior to screening with:
- Controlled or partly controlled based on an Asthma Control Questionnaire - 7 Items (ACQ-7) score <1.5 at screening and at randomisation.
Key exclusion criteria (16 listed)
- History of near fatal asthma or hospitalisation for asthma in intensive care unit, inpatient setting or emergency room access for asthma in the previous 6 months prior to screening, which in the judgement of the Investigator may place the subjects at undue risk;
- Recent asthma exacerbation requiring systemic corticosteroids (SCSs), or emergency room admission or hospitalisation within 3 months prior to screening and/or during the run-in period ;
- Non-persistent asthma: exercise-induced, seasonal asthma (as the only asthma-related diagnosis) not requiring daily asthma control medicine;
- Asthma subjects currently treated with any of the following :
- Respiratory disorders other than asthma
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CHF5993 pMDI with HFA-152atwo puffs BID (twice daily) | Drug | Test Treatment: CHF5993 pMDI (Pressurised Metered Dose Inhaler) with HFA-152a |
| CHF5993 pMDI with HFA-134atwo puffs BID | Drug | Reference Treatment 1: CHF5993 pMDI with HFA-134a |
| CHF718 pMDI with HFA-134atwo puffs BID | Drug | Reference Treatment 2: CHF718 pMDI with HFA-134a |
Primary outcome
Change from baseline in forced expiratory volume in 1 second (FEV1) area under the curve from time zero to 4 hours (AUC0-4h) on Day 1
Time frame: Day 1
Change from baseline in pre-dose FEV1 on Day 28
Time frame: Day 28
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Asthma
RecruitingPhase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
Asthma
RecruitingPhase 1
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Asthma, Mild Asthma
RecruitingPhase 3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control
Active, not recruitingPhase 2/3
Local Antibiotic Delivery for Community Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chiesi Clinical Trial Info Chiesi Clinical Trials contact
Piotr KUNA, MD principal investigator
Barlicki University Hospital Medical University of Lodz, Poland
167 sites in 14 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing CHF5993 pMDI with HFA-152a, CHF5993 pMDI with HFA-134a and CHF718 pMDI with HFA-134a in people with Asthma, run by Chiesi Farmaceutici S.p.A. at 167 sites in 14 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 167 sites in Argentina, Bulgaria, Germany, Ukraine, Romania and 9 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chiesi Clinical Trial Info Chiesi Clinical Trials (+39 0521 2791, clinicaltrials_info@chiesi.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in forced expiratory volume in 1 second (FEV1) area under the curve from time zero to 4 hours (AUC0-4h) on Day 1 (time frame: Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.